Your trusted destination for CME, CPD & Medical Education across the Middle East.
Saudi Friends for Thalassaemia & SCA Society, Saudi Arabia
Prof. Dr. Salwa Ibrahim Hindawi, MD, MSc, FRCPath, CTM is a Saudi-based Professor of Hematology and Transfusion Medicine at King Abdulaziz University (KAU), Jeddah, Saudi Arabia. Her professional expertise focuses on clinical hematology, blood transfusion medicine, blood safety, hemovigilance, patient blood management, quality management, and transfusion services. The Saudi Sheryan Annual Meeting currently identifies her as a Professor of Hematology and Transfusion Medicine.
Her academic affiliation is supported by recent scientific publications, which identify her with the Hematology Department, Faculty of Medicine, King Abdulaziz University, as well as the Hematology Research Unit at King Fahd Medical Research Center and the Blood Transfusion Services Unit at King Abdulaziz University Hospital in Jeddah.
Prof. Hindawi has held major professional responsibilities in Saudi and international transfusion medicine organizations. She has served as a senior scientific leader within the Saudi Society of Transfusion Medicine & Services, including Vice President and Chief Scientific Officer roles. She has also participated in international blood-safety activities through the World Health Organization (WHO), the International Society of Blood Transfusion (ISBT), and the Association for the Advancement of Blood & Biotherapies (AABB).
Her international work includes membership of the WHO Expert Committee on Biological Standardization (ECBS) and the WHO advisory panel concerning blood regulation, availability and safety (AG-BRAS). In 2026, WHO-related documentation continues to list Salwa Ibrahim Hindawi of King Abdulaziz University, Saudi Arabia, among AG-BRAS experts.
She has an established research record in transfusion medicine and hematology. Her publications address subjects including blood transfusion services in Saudi Arabia, blood donor screening, hemovigilance, blood safety, donor behavior, and quality improvement. A 2020 review in Transfusion listed her as Salwa Hindawi, MD, MSc, FRCPath, CTM, and identified her as Scientific Officer of the Saudi Society of Transfusion Medicine.
| FieldDetails | |
| Full Name | Prof. Dr. Salwa Ibrahim Hindawi |
| Credentials | MD, MSc, FRCPath, CTM |
| Profession | Physician / Professor |
| Specialty | Hematology |
| Subspecialty | Transfusion Medicine |
| Current Institution | King Abdulaziz University (KAU) |
| Department | Department of Hematology, Faculty of Medicine |
| Location | Jeddah, Saudi Arabia |
| Additional KAU affiliation | King Fahd Medical Research Center; King Abdulaziz University Hospital Blood Transfusion Services |
| Research Areas | Hematology, transfusion medicine, blood safety, hemovigilance, patient blood management |
| Professional Society | Saudi Society of Transfusion Medicine & Services |
| International Organizations | WHO, ISBT, AABB |
| ORCID | 0000-0003-3804-5434 |
| Year / PeriodCareer / Achievement | |
| 1991 | Public biographical records report postgraduate study in Hematology at the University of London, with a master's qualification. |
| 2001 onward | Historical biographical records identify her as Director of Blood Transfusion Services at King Abdulaziz University. |
| Academic career | Progressed through academic roles in Hematology and Transfusion Medicine at King Abdulaziz University, ultimately becoming Professor. KAU records list her academic field as Hematology and her Royal College of Pathologists qualification. |
| 2010s | Served in leadership roles within Saudi transfusion medicine organizations and participated in international blood-transfusion activities. WHO documentation lists her as ISBT Regional Director for the Eastern Mediterranean. |
| 2017 | Co-authored research published in PLOS ONE examining ethnicity, skin autofluorescence and cardiometabolic risk; her affiliation was the Department of Haematology, Faculty of Medicine, King Abdulaziz University. |
| 2020 | Co-authored “Evolution of Blood Transfusion Medicine in Saudi Arabia” in Transfusion, documenting the development of transfusion medicine in the Kingdom. |
| 2020s | Served as a scientific leader in the Saudi Society of Transfusion Medicine, including Vice President/Chief Scientific Officer responsibilities. |
| 2024 | Participated in international research concerning blood donor return and predictive modeling during the COVID-19 pandemic, published in Transfusion Medicine. |
| 2025 | Continued research through KAU's Hematology Department, Hematology Research Unit and Blood Transfusion Services Unit. |
| 2025–2026 | Participated in research concerning hepatitis B virus screening among blood donors, with affiliations spanning KAU hematology, blood-transfusion services and the Saudi Society of Transfusion Medicine & Services. |
| 2026 | Listed as a Professor of Hematology and Transfusion Medicine at the Sheryan Annual Meeting & Engagement. |
| 2026 | Listed in WHO-related documentation as a member of the WHO Advisory Group on Blood Regulation, Availability and Safety (AG-BRAS), representing King Abdulaziz University, Saudi Arabia. |
King Abdulaziz University (KAU), Faculty of Medicine
Department: Hematology
Location: Jeddah, Saudi Arabia
Current role: Professor of Hematology and Transfusion Medicine.
MeetingMinds Experts
MeetingMinds Experts